Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1992 1
1993 2
1994 3
1995 1
2000 2
2002 1
2004 1
2006 3
2007 1
2008 3
2009 1
2010 2
2011 1
2012 3
2013 3
2014 4
2015 4
2016 3
2017 2
2018 1
2019 1
2020 2
2021 1
2022 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Parkinson's disease severity and use of dopaminergic medications.
Fang JY, Pérez A, Christine CW, Leehey M, Aminoff MJ, Boyd JT, Morgan JC, Dhall R, Nicholas AP, Bodis-Wollner I, Zweig RM, Goudreau JL; NINDS NET-PD Investigators. Fang JY, et al. Among authors: goudreau jl. Parkinsonism Relat Disord. 2015 Mar;21(3):297-9. doi: 10.1016/j.parkreldis.2014.10.016. Epub 2014 Dec 15. Parkinsonism Relat Disord. 2015. PMID: 25541182 Free PMC article.
BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson's Disease.
Fischer DL, Auinger P, Goudreau JL, Cole-Strauss A, Kieburtz K, Elm JJ, Hacker ML, Charles PD, Lipton JW, Pickut BA, Sortwell CE. Fischer DL, et al. Among authors: goudreau jl. Neurotherapeutics. 2020 Oct;17(4):1785-1795. doi: 10.1007/s13311-020-00965-9. Epub 2020 Nov 19. Neurotherapeutics. 2020. PMID: 33215284 Free PMC article. Clinical Trial.
A call for transparent reporting to optimize the predictive value of preclinical research.
Landis SC, Amara SG, Asadullah K, Austin CP, Blumenstein R, Bradley EW, Crystal RG, Darnell RB, Ferrante RJ, Fillit H, Finkelstein R, Fisher M, Gendelman HE, Golub RM, Goudreau JL, Gross RA, Gubitz AK, Hesterlee SE, Howells DW, Huguenard J, Kelner K, Koroshetz W, Krainc D, Lazic SE, Levine MS, Macleod MR, McCall JM, Moxley RT 3rd, Narasimhan K, Noble LJ, Perrin S, Porter JD, Steward O, Unger E, Utz U, Silberberg SD. Landis SC, et al. Among authors: goudreau jl. Nature. 2012 Oct 11;490(7419):187-91. doi: 10.1038/nature11556. Nature. 2012. PMID: 23060188 Free PMC article.
Sex differences by design and outcome in the Safety of Urate Elevation in PD (SURE-PD) trial.
Schwarzschild MA, Macklin EA, Bakshi R, Battacharyya S, Logan R, Espay AJ, Hung AY, Bwala G, Goetz CG, Russell DS, Goudreau JL, Parashos SA, Saint-Hilaire MH, Rudolph A, Hare JM, Curhan GC, Ascherio A; Parkinson Study Group SURE-PD Investigators. Schwarzschild MA, et al. Among authors: goudreau jl. Neurology. 2019 Oct 1;93(14):e1328-e1338. doi: 10.1212/WNL.0000000000008194. Epub 2019 Sep 4. Neurology. 2019. PMID: 31484712 Free PMC article. Clinical Trial.
46 results